Evidence map›Paper›PMID 34912250›Full record

ArticleFrontiers in psychiatry2021

Nx4 Reduced Susceptibility to Distraction in an Attention Modulation Task.

Kathrin Mayer, Marina Krylova, Sarah Alizadeh, Hamidreza Jamalabadi, Johan van der Meer, Johannes C Vester, Britta Naschold, Myron Schultz, Martin Walter

Registry-linked trialAbstract read
In one paragraph

Article in Frontiers in psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02602275 (Neuronal Correlates of Neurexan® Action in Mildly to Moderately Stressed Probands - A Randomized, Placebo-controlled, Double-blind, Cross-over Trial of Mode of Action and Response Prediction by Functional Magnetic Resonance Imaging MRI), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02602275 phase2completednot on this map

Neuronal Correlates of Neurexan® Action in Mildly to Moderately Stressed Probands - A Randomized, Placebo-controlled, Double-blind, Cross-over Trial of Mode of Action and Response Prediction by Functional Magnetic Resonance Imaging MRI

TypeinterventionalSponsorBiologische Heilmittel Heel GmbHRan2015 to 2015Enrolled53ConditionsAcute Stress ReactionArmsNeurexan, Placebo
3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kathrin MayerDepartment of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany.
Marina KrylovaDepartment of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany.
Sarah AlizadehDepartment of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany.
Hamidreza JamalabadiDepartment of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany.
Johan van der MeerDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Amsterdam, Netherlands.
Johannes C Vesteridv Data Analysis and Study Planning, Gauting, Germany.
Britta NascholdBiologische Heilmittel Heel GmbH, Baden-Baden, Germany.
Myron SchultzBiologische Heilmittel Heel GmbH, Baden-Baden, Germany.
Martin WalterDepartment of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

attention modulationEEGERPnatural medicineNeurexanreaction timestress

Identifiers

PMID34912250
PMCPMC8667722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.